127 related articles for article (PubMed ID: 37469151)
1. The Role of CDK20 Protein in Carcinogenesis.
Chivukula S; Malkhed V
Curr Drug Targets; 2023; 24(10):790-796. PubMed ID: 37469151
[TBL] [Abstract][Full Text] [Related]
2. CDK20 interacts with KEAP1 to activate NRF2 and promotes radiochemoresistance in lung cancer cells.
Wang Q; Ma J; Lu Y; Zhang S; Huang J; Chen J; Bei JX; Yang K; Wu G; Huang K; Chen J; Xu S
Oncogene; 2017 Sep; 36(37):5321-5330. PubMed ID: 28534518
[TBL] [Abstract][Full Text] [Related]
3. CCRK is a novel signalling hub exploitable in cancer immunotherapy.
Mok MT; Zhou J; Tang W; Zeng X; Oliver AW; Ward SE; Cheng AS
Pharmacol Ther; 2018 Jun; 186():138-151. PubMed ID: 29360538
[TBL] [Abstract][Full Text] [Related]
4. Hepatoma-intrinsic CCRK inhibition diminishes myeloid-derived suppressor cell immunosuppression and enhances immune-checkpoint blockade efficacy.
Zhou J; Liu M; Sun H; Feng Y; Xu L; Chan AWH; Tong JH; Wong J; Chong CCN; Lai PBS; Wang HK; Tsang SW; Goodwin T; Liu R; Huang L; Chen Z; Sung JJ; Chow KL; To KF; Cheng AS
Gut; 2018 May; 67(5):931-944. PubMed ID: 28939663
[TBL] [Abstract][Full Text] [Related]
5. Hepatocyte-specific NRF2 activation controls fibrogenesis and carcinogenesis in steatohepatitis.
Mohs A; Otto T; Schneider KM; Peltzer M; Boekschoten M; Holland CH; Hudert CA; Kalveram L; Wiegand S; Saez-Rodriguez J; Longerich T; Hengstler JG; Trautwein C
J Hepatol; 2021 Mar; 74(3):638-648. PubMed ID: 33342543
[TBL] [Abstract][Full Text] [Related]
6. The cyclin-dependent kinase (CDK) family member PNQALRE/CCRK supports cell proliferation but has no intrinsic CDK-activating kinase (CAK) activity.
Wohlbold L; Larochelle S; Liao JC; Livshits G; Singer J; Shokat KM; Fisher RP
Cell Cycle; 2006 Mar; 5(5):546-54. PubMed ID: 16552187
[TBL] [Abstract][Full Text] [Related]
7. Functional characterisation of cell cycle-related kinase (CCRK) in colorectal cancer carcinogenesis.
An X; Ng SS; Xie D; Zeng YX; Sze J; Wang J; Chen YC; Chow BK; Lu G; Poon WS; Kung HF; Wong BC; Lin MC
Eur J Cancer; 2010 Jun; 46(9):1752-61. PubMed ID: 20466538
[TBL] [Abstract][Full Text] [Related]
8. BROMI/TBC1D32 together with CCRK/CDK20 and FAM149B1/JBTS36 contributes to intraflagellar transport turnaround involving ICK/CILK1.
Satoda Y; Noguchi T; Fujii T; Taniguchi A; Katoh Y; Nakayama K
Mol Biol Cell; 2022 Aug; 33(9):ar79. PubMed ID: 35609210
[TBL] [Abstract][Full Text] [Related]
9. Loss-of-function mutations in KEAP1 drive lung cancer progression via KEAP1/NRF2 pathway activation.
Gong M; Li Y; Ye X; Zhang L; Wang Z; Xu X; Shen Y; Zheng C
Cell Commun Signal; 2020 Jun; 18(1):98. PubMed ID: 32576270
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms for the regulation of Nrf2-mediated cell proliferation in non-small-cell lung cancers.
Yamadori T; Ishii Y; Homma S; Morishima Y; Kurishima K; Itoh K; Yamamoto M; Minami Y; Noguchi M; Hizawa N
Oncogene; 2012 Nov; 31(45):4768-77. PubMed ID: 22249257
[TBL] [Abstract][Full Text] [Related]
11. Regulation of CAK kinase activity by p53.
Schneider E; Montenarh M; Wagner P
Oncogene; 1998 Nov; 17(21):2733-41. PubMed ID: 9840937
[TBL] [Abstract][Full Text] [Related]
12. NF-κB and Keap1 Interaction Represses Nrf2-Mediated Antioxidant Response in Rabbit Hemorrhagic Disease Virus Infection.
Hu B; Wei H; Song Y; Chen M; Fan Z; Qiu R; Zhu W; Xu W; Wang F
J Virol; 2020 May; 94(10):. PubMed ID: 32161178
[TBL] [Abstract][Full Text] [Related]
13. The discovery and characterization of K-563, a novel inhibitor of the Keap1/Nrf2 pathway produced by Streptomyces sp.
Hori R; Yamaguchi K; Sato H; Watanabe M; Tsutsumi K; Iwamoto S; Abe M; Onodera H; Nakamura S; Nakai R
Cancer Med; 2019 Mar; 8(3):1157-1168. PubMed ID: 30735010
[TBL] [Abstract][Full Text] [Related]
14. The KEAP1-NRF2 System: a Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis.
Yamamoto M; Kensler TW; Motohashi H
Physiol Rev; 2018 Jul; 98(3):1169-1203. PubMed ID: 29717933
[TBL] [Abstract][Full Text] [Related]
15. Cell cycle-related kinase: a novel candidate oncogene in human glioblastoma.
Ng SS; Cheung YT; An XM; Chen YC; Li M; Li GH; Cheung W; Sze J; Lai L; Peng Y; Xia HH; Wong BC; Leung SY; Xie D; He ML; Kung HF; Lin MC
J Natl Cancer Inst; 2007 Jun; 99(12):936-48. PubMed ID: 17565152
[TBL] [Abstract][Full Text] [Related]
16. A CCRK-EZH2 epigenetic circuitry drives hepatocarcinogenesis and associates with tumor recurrence and poor survival of patients.
Feng H; Yu Z; Tian Y; Lee YY; Li MS; Go MY; Cheung YS; Lai PB; Chan AM; To KF; Chan HL; Sung JJ; Cheng AS
J Hepatol; 2015 May; 62(5):1100-11. PubMed ID: 25500144
[TBL] [Abstract][Full Text] [Related]
17. GSTM3 deficiency impedes DNA mismatch repair to promote gastric tumorigenesis via CAND1/NRF2-KEAP1 signaling.
Chen T; Jinlin D; Wang F; Yuan Z; Xue J; Lu T; Huang W; Liu Y; Zhang Y
Cancer Lett; 2022 Jul; 538():215692. PubMed ID: 35487311
[TBL] [Abstract][Full Text] [Related]
18. New insights into the mechanism of Keap1-Nrf2 interaction based on cancer-associated mutations.
Cheng L; Wang H; Li S; Liu Z; Wang C
Life Sci; 2021 Oct; 282():119791. PubMed ID: 34229009
[TBL] [Abstract][Full Text] [Related]
19. Catalpol Protects ARPE-19 Cells against Oxidative Stress via Activation of the Keap1/Nrf2/ARE Pathway.
You L; Peng H; Liu J; Cai M; Wu H; Zhang Z; Bai J; Yao Y; Dong X; Yin X; Ni J
Cells; 2021 Oct; 10(10):. PubMed ID: 34685615
[TBL] [Abstract][Full Text] [Related]
20. LKB1 and KEAP1/NRF2 Pathways Cooperatively Promote Metabolic Reprogramming with Enhanced Glutamine Dependence in
Galan-Cobo A; Sitthideatphaiboon P; Qu X; Poteete A; Pisegna MA; Tong P; Chen PH; Boroughs LK; Rodriguez MLM; Zhang W; Parlati F; Wang J; Gandhi V; Skoulidis F; DeBerardinis RJ; Minna JD; Heymach JV
Cancer Res; 2019 Jul; 79(13):3251-3267. PubMed ID: 31040157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
